Compliance Rate
Compliance Rate
40.0%
Compliant submissions
2
Incompliant submissions
3
Total trials
5
My Organizations' Clinical Trials
Showing 1250 of 2418 entries
View as:
Phase: N/A
Priority: Normal
Start: 04/20/24
End: 03/01/26
Due: 03/01/27
Phase: N/A
Priority: Normal
Start: 12/31/02
End: 12/31/23
Due: 12/31/24
Phase: N/A
Priority: Normal
Start: 10/01/18
End: 03/21/22
Due: 03/21/23
Phase: N/A
Priority: Normal
Start: 07/31/07
End: 08/31/15
Due: 08/31/16
Phase: N/A
Priority: Normal
Start: 01/27/21
End: 02/10/21
Due: 02/10/22
Phase: N/A
Priority: Normal
Start: 03/18/21
End: 11/20/21
Due: 11/20/22
Phase: N/A
Priority: Normal
Start: 09/30/16
End: 12/31/17
Due: 12/31/18
Phase: N/A
Priority: Normal
Start: 07/18/17
End: 01/29/18
Due: 01/29/19
Phase: N/A
Priority: Normal
Start: 08/31/11
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 11/30/14
End: 04/30/17
Due: 04/30/18
Phase: N/A
Priority: Normal
Start: 10/31/19
End: 08/04/21
Due: 08/04/22
Phase: N/A
Priority: Normal
Start: 03/31/15
End: 01/31/16
Due: 01/31/17
Phase: N/A
Priority: Normal
Start: 11/30/06
End: 06/30/10
Due: 06/30/11
Phase: N/A
Priority: Normal
Start: 06/18/24
End: 02/28/27
Due: 02/28/28
Phase: N/A
Priority: Normal
Start: 02/24/21
End: 04/13/21
Due: 04/13/22
Phase: N/A
Priority: Normal
Start: 08/31/03
End: 09/30/10
Due: 09/30/11
Phase: N/A
Priority: Normal
Start: 05/31/11
End: 09/30/12
Due: 09/30/13
Phase: N/A
Priority: Normal
Start: 06/01/25
End: 06/30/27
Due: 06/30/28
Phase: N/A
Priority: Normal
Start: 09/30/16
End: 04/10/19
Due: 04/10/20
Phase: N/A
Priority: Normal
Start: 12/20/22
End: 04/30/25
Due: 04/30/26
Phase: N/A
Priority: Normal
Start: 02/01/24
End: 02/18/25
Due: 02/18/26
A Study of Dabrafenib and/or Trametinib in Patients With Relapsed and/or Refractory Multiple Myeloma
Phase: N/A
Priority: Normal
Start: 06/21/17
End: 09/15/24
Due: 09/15/25
Phase: N/A
Priority: Normal
Start: 10/13/21
End: 07/27/23
Due: 07/27/24
Phase: N/A
Priority: Normal
Start: 02/11/22
End: 10/31/24
Due: 10/31/25
Phase: N/A
Priority: Normal
Start: 09/16/20
End: 12/31/25
Due: 12/31/26